Hearing Loss Trial, Recruiting (NCT06936696)

Hearing Loss Trial, Recruiting NCT06936696 Sponsor: Vanderbilt University Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06936696 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Be between 4 years and 9 years 11 months old
Have a permanent hearing loss that was present before learning to speak, caused by a problem in the inner ear or hearing nerve
Use spoken English as their main language at home (more than half of the time)
Score at least 70 on a nonverbal thinking skills test called the Leiter
Score at least 70 on a listening and language understanding test called the OWLS-II
Make at least two specific types of speech sound mistakes that are considered appropriate targets based on typical speech development and ability to imitate sounds (confirm with trial site)

Who may not be able to join:

Have a motor speech disorder, such as childhood apraxia of speech (a condition affecting the muscle movements needed for speech)
Have a structural or functional problem with the mouth or related areas, such as a cleft palate
Have a diagnosis of autism spectrum disorder
Have a diagnosis of ADHD (Attention-Deficit/Hyperactivity Disorder)
Have a vision problem that has not been corrected with glasses or contact lenses

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 330-814-1748

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06936696

Sponsor: Vanderbilt University

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 330-814-1748

More information: https://clinicaltrials.gov/study/NCT06936696

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Be between 4 years and 9 years 11 months old
Have a permanent hearing loss that was present before learning to speak, caused by a problem in the inner ear or hearing nerve
Use spoken English as their main language at home (more than half of the time)
Score at least 70 on a nonverbal thinking skills test called the Leiter
Score at least 70 on a listening and language understanding test called the OWLS-II
Make at least two specific types of speech sound mistakes that are considered appropriate targets based on typical speech development and ability to imitate sounds (confirm with trial site)

Who may not be able to join:

Have a motor speech disorder, such as childhood apraxia of speech (a condition affecting the muscle movements needed for speech)
Have a structural or functional problem with the mouth or related areas, such as a cleft palate
Have a diagnosis of autism spectrum disorder
Have a diagnosis of ADHD (Attention-Deficit/Hyperactivity Disorder)
Have a vision problem that has not been corrected with glasses or contact lenses

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vanderbilt University

Registry

ClinicalTrials.gov

Start date

10 June 2025

Est. completion

1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Target phoneme production accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov